DEANNA CAVALLARO FATZINGER: Open Payments
NPI 1437924867 · LANSDALE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,426 in 69 payments from 24 companies in 2025. Trend: 2023 $48 · 2024 $1,048 · 2025 $1,426
Food & beverage: $1,426
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $223 |
| Novo Nordisk Inc | 8 | $155 |
| Lilly USA, LLC | 7 | $143 |
| Sumitomo Pharma America, Inc. | 5 | $100 |
| ABBVIE INC. | 5 | $88 |
| Corcept Therapeutics | 3 | $85 |
| Otsuka America Pharmaceutical, Inc. | 4 | $82 |
| Abbott Laboratories | 4 | $78 |
| Bausch Health US, LLC | 3 | $65 |
| GlaxoSmithKline, LLC. | 2 | $52 |
Products named: REXULTI, ELIQUIS, GEMTESA, Korlym, JARDIANCE, FREESTYLE LIBRE 3, PREVNAR 20, WELLBUTRIN.
Industry payments across PA — which companies pay providers there.
